From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Put your workers on a 4 day week on full pay and watch revenues rocket: pseudo capitalism it is so easy when your sales are pure fiction!

By Tom Winnifrith | Thursday 9 March 2023


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


A pilot scheme where workers got full pay for doing just 4 days a week was recently hailed by those organising it as a triumph and among those wheeled out to boast of its success was David Richards MBE of Wandisco (WAND). claiming his company's sales had rocketed seven fold and productivity was up 25%. In fact...

Mr Richards was considering putting staff on a 3 day week for even bigger gains. Give the man awarded an MBE for offering up data to support bogus science in the scamdemic another gong. Unfortunately it today emerged that those sale numbers were driven by fraud and that, in fact were not $24 million as had been claimed but just $9 million. As a result of this Wandisco is now in a financial crisis which may well see it go bust, a $1 billion blow up.

Maybe if Richards puts his staff on a two day week on full pay it will be even better?


This story is available to all readers
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:


Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 17:27:24